Compare FCAP & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCAP | EDAP |
|---|---|---|
| Founded | 1891 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.0M | 163.4M |
| IPO Year | 1998 | 1998 |
| Metric | FCAP | EDAP |
|---|---|---|
| Price | $50.30 | $4.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 3.1K | ★ 67.0K |
| Earning Date | 04-24-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 3.43 | N/A |
| Revenue | ★ $7,059,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | $14.76 | ★ N/A |
| Revenue Growth | ★ 0.71 | N/A |
| 52 Week Low | $33.88 | $1.21 |
| 52 Week High | $71.00 | $5.05 |
| Indicator | FCAP | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 47.73 |
| Support Level | $46.64 | $3.89 |
| Resistance Level | $50.75 | $4.24 |
| Average True Range (ATR) | 1.49 | 0.33 |
| MACD | -0.21 | -0.08 |
| Stochastic Oscillator | 15.37 | 43.86 |
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.